Search results
Results From The WOW.Com Content Network
According to a January survey of 1,245 Americans from BuzzRx, a prescription discounting service, one in 10 Americans have had their medicine confiscated while traveling, either by the ...
The Drugs and Cosmetics Act, 1940 is an act of the Parliament of India which regulates the import, manufacture and distribution of drugs in India. [1] The primary objective of the act is to ensure that the drugs and cosmetics sold in India are safe, effective and conform to state quality standards. [2]
Medical professionals say those with chronic illness can travel safely by taking extra precautions. Write down your conditions, medications in the country's language: How to travel with a chronic ...
Recreational drug tourism is travel for the purpose of obtaining or using drugs for recreational use that are unavailable, illegal or very expensive in one's home jurisdiction. A drug tourist may cross a national border to obtain a drug that is not sold in one's home country, or to obtain an illegal drug that is more available in the visited ...
"Drugs and Cosmetics Rules, 1945" (PDF). Central Drugs Standard Control Organization.Archived from the original (PDF) on 31 October 2005.; A Review on the Current Classification and Regulatory Provisions for Medicines in Drug & Cosmetic Act, in the light of Present Day Context Recommendations for Drugs & Cosmetics Rules with context of Drug Schedules
In some markets, drug prices are set or influenced by the prices in other, nearby markets. [1] In Europe, for example, people freely and easily travel to different countries, and the price of a certain drug in one country affects the price in other, nearby countries. [1]
Gurgaon is India's largest Medical Tourism hub, [102] followed by Chennai, which is regarded as "India's Health City" as it attracts 45% of health tourists visiting India and 40% of domestic health tourists. India's medical tourism sector was expected to experience an annual growth rate of 30% from 2012, making it a $2 billion industry by 2015.
The Act is designed to fulfill India's treaty obligations under the Single Convention on Narcotic Drugs, Convention on Psychotropic Substances, and United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances. The Act has been amended three times - in 1988, 2001, and most recently in 2014.